Longevity Pioneer Bryan Johnson Diagnosed With Incurable Autoimmune Gastritis

Bryan Johnson walked into a podcast studio in Mumbai with his own air purifier, a man so committed to controlling every variable of his existence that he had brought his own atmosphere. When the city's air quality overwhelmed even that technology, he left. The moment became a perfect encapsulation of his life's work: a centi-millionaire entrepreneur spending roughly $2 million each year on an obsessive project called Project Blueprint, designed to delay aging as far as science will allow.

His routine is the kind of thing that reads like satire until you realize he's serious. Plant-based diet, meticulously tracked. Exercise on a rigid schedule. Early bedtimes. Dozens of supplements. Endless medical tests. Almost every biological marker gets measured, analyzed, and shared publicly. For someone who has built a global reputation on the premise that death itself might be optional, the announcement he made in May 2026 landed like a contradiction he couldn't optimize away: autoimmune gastritis, a rare disease in which the immune system attacks the stomach lining. There is no cure. It can only be managed.

Autoimmune gastritis affects somewhere between 2 and 5 percent of the global population, though many people never know they have it because the symptoms blur together with a dozen other things—abdominal pain, nausea, appetite loss, unexplained weight loss, low iron. Johnson had been carrying one of those warning signs for more than a decade. For 11 years, his ferritin levels stayed unusually low, the protein that stores iron in the body. He tried different approaches. Nothing worked. He didn't know he was looking at the early signature of a disease that would eventually damage his stomach lining irreversibly, leaving him vulnerable to nutritional deficiency, anemia, and over time, elevated cancer risk.

The diagnosis came almost by accident. Johnson was preparing for a new $1 million annual longevity initiative called Immortals Care and underwent exhaustive testing. A colonoscopy ruled out cancer. A bidirectional endoscopy—examining both upper and lower digestive tract—along with blood work revealed elevated anti-parietal cell antibodies. A stomach biopsy confirmed early damage. At 48 years old, the man who had spent his adult life trying to become immortal had run into something his money and discipline couldn't reverse.

Johnson's path to this moment had its own arc. He grew up on fast food, sugary drinks, processed meals. His twenties were, as he described them, "a few healthy years" before his lifestyle deteriorated while he was raising a family and building businesses. During that period, he also battled severe chronic depression. Somewhere in that timeline, his body began developing autoimmune processes. He was diagnosed with hypothyroidism at 21 and managed it successfully for nearly three decades. But looking back now, he understands his body had been signaling distress all along.

The irony is sharp: Johnson discovered the disease while trying to become even healthier. He had also conducted experiments that generated worldwide attention—receiving plasma transfusions from his teenage son as part of an anti-aging trial, an experiment he later admitted produced no measurable benefit and abandoned. Yet this diagnosis, this incurable condition, he is treating as another scientific problem to be solved.

He and his team are now closely monitoring his iron levels and other biomarkers while exploring experimental approaches: therapies targeting immune signaling proteins, rebuilding regulatory T-cells, engineered cell therapies. None of these have proven effective for autoimmune gastritis. The disease remains incurable. But Johnson has positioned his thinking differently. He believes medicine is entering an era where diseases once considered incurable deserve to be challenged using artificial intelligence, multiomics, and advanced genetic and cellular engineering. "In the age of AI, multiomics, and custom-built DNA, proteins, and cells, no condition should be presumed incurable simply because no one has yet tried to cure it with today's stack," he wrote.

For someone who built an entire philosophy around pushing the limits of human longevity, autoimmune gastritis has become his most personal experiment yet. Whether he succeeds is a question only time will answer.